BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34798867)

  • 1. Prediction of the degree of pathological differentiation in tongue squamous cell carcinoma based on radiomics analysis of magnetic resonance images.
    Yu B; Huang C; Xu J; Liu S; Guan Y; Li T; Zheng X; Ding J
    BMC Oral Health; 2021 Nov; 21(1):585. PubMed ID: 34798867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Prognosis of Tongue Squamous Cell Carcinoma Based on Clinical MR Imaging Data Modeling.
    Liu J; Song L; Zhou J; Yu M; Hu Y; Zhang J; Song P; Ye Y; Wang J; Feng G; Guo H; An P
    Technol Cancer Res Treat; 2023; 22():15330338231207006. PubMed ID: 37872687
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of radiomics machine learning models based on multimodal MRI with different sequence combinations in predicting cervical lymph node metastasis in oral tongue squamous cell carcinoma patients.
    Liu S; Zhang A; Xiong J; Su X; Zhou Y; Li Y; Zhang Z; Li Z; Liu F
    Head Neck; 2024 Mar; 46(3):513-527. PubMed ID: 38108536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics of apparent diffusion coefficient maps to predict histologic grade in squamous cell carcinoma of the oral tongue and floor of mouth: a preliminary study.
    Ren J; Qi M; Yuan Y; Tao X
    Acta Radiol; 2021 Apr; 62(4):453-461. PubMed ID: 32536260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.
    Kawahara D; Murakami Y; Tani S; Nagata Y
    Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based MRI radiomics for assessing the level of tumor infiltrating lymphocytes in oral tongue squamous cell carcinoma: a pilot study.
    Ren J; Yang G; Song Y; Zhang C; Yuan Y
    BMC Med Imaging; 2024 Feb; 24(1):33. PubMed ID: 38317076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics analysis of [
    Kudoh T; Haga A; Kudoh K; Takahashi A; Sasaki M; Kudo Y; Ikushima H; Miyamoto Y
    Oral Radiol; 2023 Jan; 39(1):41-50. PubMed ID: 35254609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
    Yang X; Yuan C; Zhang Y; Wang Z
    Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of MR Imaging Features in Differentiation of Renal Changes in Patients With Stage III Type 2 Diabetic Nephropathy and Normal Subjects.
    Yu B; Huang C; Fan X; Li F; Zhang J; Song Z; Zhi N; Ding J
    Front Endocrinol (Lausanne); 2022; 13():846407. PubMed ID: 35600605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
    Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
    Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CT-based radiomics analysis for evaluating the differentiation degree of esophageal squamous carcinoma].
    Cheng L; Wu L; Chen S; Ye W; Liu Z; Liang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):251-256. PubMed ID: 30971516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
    Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
    J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningiomas: Preoperative predictive histopathological grading based on radiomics of MRI.
    Han Y; Wang T; Wu P; Zhang H; Chen H; Yang C
    Magn Reson Imaging; 2021 Apr; 77():36-43. PubMed ID: 33220449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features.
    Ma X; Shen F; Jia Y; Xia Y; Li Q; Lu J
    BMC Med Imaging; 2019 Nov; 19(1):86. PubMed ID: 31747902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of radiomics signature based on biparametric MRI for preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma.
    He J; Zhang H; Wang X; Sun Z; Ge Y; Wang K; Yu C; Deng Z; Feng J; Xu X; Hu S
    J Xray Sci Technol; 2021; 29(1):171-183. PubMed ID: 33325448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.